Biogen is a Massachusetts-based biotechnology company that discovers, develops, and commercializes drugs for the treatment of neurological diseases.
Read moreAnnual Revenue
$10.8B
Biogen's revenue is the ranked 20th among it's top 10 competitors. The top 10 competitors average 34.4B. Over the last four quarters, Biogen's revenue has decreased by 8.8%. Specifically, in Q1 2022's revenue was $2.5B; in Q4 2021, it was $2.7B; in Q3 2021, it was $2.8B; in Q2 2021, Biogen's revenue was $2.8B.